60 Degrees Pharmaceuticals, Inc. (SXTP) compared with its closest peers (REVB, FBLG, GRI, GNPX, ARTL). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $4.32M | -0.0 |
| FibroBiologics, Inc. Common Stock (FBLG) | $4.17M | -0.6 |
| GRI Bio, Inc. (GRI) | $3.65M | -0.0 |
| Genprex, Inc. (GNPX) | $3.25M | -0.1 |
| Artelo Biosciences, Inc. (ARTL) | $3.18M | -0.1 |
| Ernexa Therapeutics Inc. (ERNA) | $2.90M | — |
| Nexentis Technologies Inc. (NXTS) | $2.60M | — |
| Onconetix, Inc. (ONCO) | $2.56M | -0.1 |
| HCW Biologics Inc. (HCWB) | $2.45M | — |
| Oragenics, Inc. (OGEN) | $2.35M | -0.2 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
SXTP overview · SXTP earnings · SXTP financials · SXTP KPIs · SXTP investor relations · SXTP ownership · SXTP filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.